Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2014
10/16/2014US20140309240 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309237 Compounds that modulate intracellular calcium
10/16/2014US20140309213 Inhibitors of the renal outer medullary potassium channel
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309208 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/16/2014US20140308317 Polymeric Compounds And Methods Of Making And Using The Same
10/14/2014US8859777 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
10/14/2014US8859607 Crystalline complexes of agriculturally active organic compounds
10/14/2014US8859606 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
10/14/2014US8859605 Cysteine protease inhibitors
10/14/2014US8859602 Inhibitors of c-fms kinase
10/14/2014US8859600 Acetone solvate crystals of trityl olmesartan medoxomil
10/14/2014US8859596 Compounds as cannabinoid receptor ligands
10/14/2014US8859595 Potent and selective inhibitors of hepatitis C virus
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859588 Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
10/14/2014US8859586 Cyclohexyl isoquinolinone compounds
10/14/2014US8859580 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
10/14/2014US8859574 Compounds and compositions as kinase inhibitors
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859535 Hydroxy substituted isoquinolinone derivatives
10/14/2014US8859534 2-carboxamide-7-piperazinyl-benzofuran derivatives
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
10/09/2014WO2014165075A1 Antibacterial agents
10/09/2014WO2014164756A1 Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
10/09/2014WO2014164286A1 Dual sglt1/sglt2 inhibitors
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014162126A1 Urea derivatives useful as kinase inhibitors
10/09/2014WO2014161888A1 N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
10/09/2014WO2014161808A1 Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]jpyridin-5-yl)-4- quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4- quinazolinamine derivatives as perk inhibitors
10/09/2014US20140303207 Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
10/09/2014US20140303206 3-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors
10/09/2014US20140303185 Novel polymorphs of vilazodone hydrochloride
10/09/2014US20140303182 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/09/2014US20140303168 Phthalazines as potassium ion channel inhibitors
10/09/2014US20140303167 Cdk9 inhibitors in the treatment of midline carcinoma
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303151 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
10/09/2014US20140303150 Ingenol-3-acylates iii and ingenol-3-carbamates
10/09/2014US20140303139 Pyrimidines as sodium channel blockers
10/09/2014US20140302010 Substituted benzimidazoles
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/09/2014US20140301944 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
10/08/2014EP2786985A2 Antagonists of the glucagon receptor
10/08/2014EP2785711A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785710A1 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
10/08/2014EP2785709A1 Aminopyrimidine derivatives as lrrk2 modulators
10/08/2014EP2785708A1 Insecticidal triazinone derivatives
10/08/2014EP2785704A1 Novel combination of n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide and folfox
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/08/2014EP2785692A1 Substituted anilines as ccr(4) antagonists
10/08/2014EP2785445A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction
10/07/2014US8853429 Process and intermediate compounds useful in the preparation of statins
10/07/2014US8853427 Neprilysin inhibitors
10/07/2014US8853420 Compounds
10/07/2014US8853418 Cyclopentylpyrazoles as N-type calcium channel blockers
10/07/2014US8853412 Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853396 Methods for the preparation of lapatinib and the salts thereof
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853255 3-phenoxymethylpyrrolidine compounds
10/07/2014US8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
10/07/2014US8853214 Pyridazine compounds for controlling invertebrate pests
10/07/2014US8853205 Heteropyrrole analogs acting on cannabinoid receptors
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/07/2014US8853196 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
10/02/2014WO2014160810A1 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160502A1 Uridine nucleoside derivatives, compositions and methods of use
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014160017A1 Pyridine cdk9 kinase inhibitors
10/02/2014WO2014159690A1 Dna-pk inhibitors
10/02/2014WO2014159657A1 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
10/02/2014WO2014158045A1 Dimeric quaternary pyridinium salts possessing biocidal activity
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157687A1 1,2,4-triazine-6-carboxamide derivative with acetamide group
10/02/2014WO2014157618A1 Organic electroluminescent element, and lighting device and display device which are provided with same
10/02/2014WO2014157574A1 Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device
10/02/2014WO2014157494A1 Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157009A1 Photoelectric conversion element, imaging element and optical sensor
10/02/2014WO2014154794A1 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
10/02/2014WO2014154682A1 Novel viral replication inhibitors
10/02/2014WO2014154122A1 Bicyclol amino-acid ester, preparation method for same, and application thereof
10/02/2014WO2014153624A1 Antibacterial compounds
10/02/2014US20140296535 Method for producing 4-benzyl-1-methyl-6-oxabicyclo[3,2,0]heptane derivative
10/02/2014US20140296534 Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
10/02/2014US20140296532 Compositions and methods for the treatment of malaria
10/02/2014US20140296531 Novel semi-synthetic small molecules for the treatment parasitic disease
10/02/2014US20140296514 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/02/2014US20140296313 (4-Phenylimidazol-2-yl) Ethylamine Derivatives Useful As Sodium Channel Modulators
10/02/2014US20140296292 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
10/02/2014US20140296287 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
10/02/2014US20140296270 STAT3 Inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 694